Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC

Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC

Programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) is an important pair of immune checkpoints (IC), which play an essential role in the immune escaping process of tumors. Anti-PD-1/PD-L1 immunotherapy can block the suppression effect of the immune system produced by tumor cells through...

Full description

Bibliographic Details
Main Authors: Fenglong Bie, He Tian, Nan Sun, Ruochuan Zang, Moyan Zhang, Peng Song, Lei Liu, Yue Peng, Guangyu Bai, Bolun Zhou, Shugeng Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer (NSCLC)
programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1)
immunotherapy
predictive biomarkers
drug resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.769124/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.769124/full

Similar Items